Visteon Corp Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $3.8B-2.5% YoYTTM through 30 Jun 2026
Net Income $143M-51.7% YoYTTM through 30 Jun 2026
Free Cash Flow $224MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 11.8% |
| EBITDA Margin | 10.2% |
| Operating Margin | 7.2% |
| Net Margin | 3.8% |
Returns
8.9%ROE
4.1%ROA
11.3%ROIC
Balance Sheet Health
Debt / Equity0.19x
Current Ratio1.78x
Net Debt-$385Mnet cash position
Cash & Equivalents$648M
Quality Metrics
Altman Z-Score3.59
Piotroski F-Score5 / 9
FCF Margin5.9%
Rule of 406.9
Earnings-Beat Rate75.0%
Multi-Year Trend
RevenueFY2025: $3.8B
Diluted EPS$5.21TTMFY2025: $7.28
Dividend
$0.75Per share, FY20260.82%Yield1 yrsStreak
Capital Allocation
R&D Spend$220M
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.